352 related articles for article (PubMed ID: 9278467)
1. Low-molecular-weight heparins.
Weitz JI
N Engl J Med; 1997 Sep; 337(10):688-98. PubMed ID: 9278467
[No Abstract] [Full Text] [Related]
2. Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
Hull RD; Raskob GE; Rosenbloom D; Pineo GF; Lerner RG; Gafni A; Trowbridge AA; Elliott CG; Green D; Feinglass J
Arch Intern Med; 1997 Feb; 157(3):289-94. PubMed ID: 9040295
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
Raskob GE
Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
[TBL] [Abstract][Full Text] [Related]
4. Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.
Kakkar VV
Semin Hematol; 1997 Oct; 34(4 Suppl 4):9-19. PubMed ID: 9399405
[No Abstract] [Full Text] [Related]
5. New heparin is no heavyweight.
Feinberg AW
Health News; 2000 Aug; 6(8):5-6. PubMed ID: 10948870
[No Abstract] [Full Text] [Related]
6. Low-molecular-weight heparin for initial treatment of venous thromboembolism.
Brewer D
Am Fam Physician; 2005 Jul; 72(1):75-6. PubMed ID: 16035683
[No Abstract] [Full Text] [Related]
7. Current and potential uses of low molecular weight heparin: a review and an economic analysis.
Seo P; Locke CF
Am J Manag Care; 2000 Apr; 6(4):498-506; quiz 507-8. PubMed ID: 10977456
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH
Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253
[TBL] [Abstract][Full Text] [Related]
9. [Low molecular weight heparins].
Schröder F; Weiss T
Dtsch Med Wochenschr; 2002 Aug; 127(31-32):1645-7. PubMed ID: 12168158
[No Abstract] [Full Text] [Related]
10. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
Caprini JA; Arcelus J; Sehgal LR; Cohen EB; Reyna JJ
Int Angiol; 2002 Mar; 21(1):78-85. PubMed ID: 11941278
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin in treatment of venous thromboembolism. An emerging theme.
Hull RD; Pineo GF
Int Angiol; 1998 Sep; 17(3):131-4. PubMed ID: 9821024
[No Abstract] [Full Text] [Related]
13. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular weight heparin as prophylaxis against thromboembolism after total hip replacement--is it worth the price?
Persson BM
Acta Orthop Scand; 2000 Apr; 71(2):215-6. PubMed ID: 10852334
[No Abstract] [Full Text] [Related]
16. [Low molecular weight heparins: mechanisms of action and pharmococynetics. Clinical advantages over the classic unfractioned heparins].
Campos M
Rev Port Cir Cardiotorac Vasc; 2003; 10(2):61-7. PubMed ID: 15094887
[TBL] [Abstract][Full Text] [Related]
17. [State of the art: low-molecular-weight heparin and beyond].
Cimminiello C; Casali G; Vitali L
Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
[TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparin prophylaxis against thromboembolism after total hip replacement--the never-ending story?
Dahl OE; Bergqvist D; Cohen AT; Frostick SP; Hull RD
Acta Orthop Scand; 2001 Apr; 72(2):199-204. PubMed ID: 11372955
[No Abstract] [Full Text] [Related]
19. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
Edwards JL
JAMA; 2007 Jan; 297(3):262; author reply 263. PubMed ID: 17227973
[No Abstract] [Full Text] [Related]
20. [Prophylaxis of venous thrombosis, yes but...].
Korin JD; Sánchez Avalos JC
Medicina (B Aires); 1996; 56(3):299-307. PubMed ID: 9035489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
